Your prescriber may recommend holding your current dose for 24 weeks before advancing if you develop moderate gastrointestinal symptoms
But some people experience appetite suppression so aggressively that they struggle to eat enough to meet basic nutritional needs
It is worth noting, they say, given their cardiovascular history, that SELECT patients were already on other cardio-protective medications, for example, to tackle cholesterol and blood pressure, meaning semaglutide had benefits on top of these other agents
The 2025 NEJM trial comparing tirzepatide directly against semaglutide showed 20.2% versus 13.7% weight loss over the same treatment period
increases the muscles performance and overall body endurance by reducing muscle fatigue
Commonly prescribed weight loss medications include: Orforglipron (Foundayo) Foundayo is the brand name for orforglipron, a small-molecule, non-peptide GLP-1 receptor agonist